Women’s Health Care Utilization among Harder-to-Reach HIV-Infected Women ever on Antiretroviral Therapy in British Columbia
Table 1
Baseline characteristics of the HIV-infected women in the LISA cohort () by women’s health care (WHC) utilization (yes versus no).
WHC utilization
value
All ()
Yes ()
No ()
Demographic variables
Age at interview (years) (median (IQR))
41 (34–46)
41 (34–46)
41 (36–46)
0.70
Aboriginal ancestry (% Y)
114 (49%)
87 (49%)
27 (52%)
0.67
Health authority (HA)
<0.01
(i) Vancouver coastal HA
136 (60%)
111 (63%)
25 (49%)
(ii) Interior HA
11 (5%)
10 (6%)
1 (2%)
(iii) Northern HA
10 (4%)
7 (4%)
3 (6%)
(iv) Vancouver island HA
22 (10%)
10 (6%)
12 (24%)
(v) Fraser HA
48 (21%)
38 (22%)
10 (20%)
Rural residency (% rural)*
3 (2%)
3 (2%)
0 (0%)
0.99
Marital status (% Y)
42 (18%)
29 (16%)
13 (25%)
0.15
Sociodemographic variables
High school or greater (% Y)
108 (47%)
87 (49%)
21 (40%)
0.30
Employment (% Y)
34 (15%)
31 (17%)
3 (6%)
0.04
Annual income < $15,000 (% Y)
166 (72%)
119 (66%)
47 (92%)
<0.01
Housing stability (% Y)
143 (62%)
118 (66%)
25 (48%)
0.02
Food security (% Y)
54 (23%)
44 (25%)
10 (19%)
0.41
Psychosocial variables
HIV-related stigma (scale, median (IQR))
53 (38–65)
53 (38–68)
50 (38–65)
0.63
Perceived neighbourhood problems (scale, median (IQR))
35 (15–62)
35 (15–62)
35 (19–62)
0.98
Perceived neighbourhood cohesion (scale, median (IQR))
56 (43–66)
56 (44–69)
51 (35–62)
0.02
Quality of life (scale, median (IQR))
(i) Overall function
43 (29–64)
43 (25–64)
43 (32–64)
0.88
(ii) Life satisfaction
69 (50–75)
69 (53–78)
63 (47–75)
0.07
(iii) Health worry
45 (30–65)
45 (30–65)
45 (25–65)
0.79
(iv) Financial worry
38 (19–63)
38 (19–63)
38 (25–56)
0.50
(v) Medical worry
69 (56–75)
69 (56–75)
63 (56–75)
0.10
(vi) Disclosure worry
50 (35–65)
50 (35–65)
55 (35–65)
0.67
(vii) HIV Mastery
50 (42–75)
58 (42–75)
50 (42–75)
0.79
(viii) Provider trust
92 (75–100)
92 (75–100)
83 (75–100)
<0.01
(ix) Sexual function
50 (42–67)
50 (42–67)
50 (42–58)
0.58
Behavioural variables
Alcohol use at time of interview (% Y)
105 (48%)
79 (47%)
26 (52%)
0.54
Illicit drug use at time of interview (% Y)
123 (53%)
85 (48%)
38 (73%)
<0.01
Injection of drugs at time of interview (% Y)
53 (23%)
37 (21%)
16 (31%)
0.13
Sexually active in last 6 months (% Y)
125 (54%)
100 (56%)
25 (48%)
0.32
Condom use of sexually active participants** (% Y)
46 (40%)
36 (40%)
10 (42%)
0.85
Sex trade history*** (% Y)
71 (57%)
52 (55%)
19 (66%)
0.30
Pregnancy intention (% Y)
32 (14%)
26 (15%)
6 (12%)
0.58
Number of births in life time (median (IQR))
2 (1–3)
2 (1–4)
2 (1–3)
0.43
Individual health status variables
Ever diagnosed with HPV (% Y)
18 (8%)
15 (8%)
3 (6%)
0.53
Ever diagnosed with chlamydia (% Y)
48 (21%)
33 (18%)
15 (29%)
0.10
Ever diagnosed with gonorrhea (% Y)
38 (16%)
28 (16%)
10 (19%)
0.54
Ever diagnosed with syphilis (% Y)
22 (10%)
15 (8%)
7 (13%)
0.27
Abnormal Pap smear in last 6 months (% Y)****
34 (17%)
28 (17%)
6 (15%)
0.75
Symptoms of depression (% Y)
156 (68%)
121 (68%)
35 (67%)
0.97
HIV clinical variables
ART status at time of interview (% Y)
177 (77%)
141 (79%)
36 (69%)
0.15
CD4 count at time of interview (median (IQR))
300 (170–470)
290 (170–470)
310 (175–475)
0.85
pVL (log 10) at time of interview (median (IQR))
1.7 (1.5–3.1)
1.7 (1.5–3.1)
1.7 (1.5–3.0)
0.46
VL suppression (% Y)
140 (61%)
111 (62%)
29 (56%)
0.42
30% of the data are missing ().
**50% of the data are missing ().
***46% of the data are missing ().
****only participants who answered “yes” or “no” were included in the denominator.
